Key result
Primary cardiac angiosarcoma is a rare and aggressive malignancy with a poor prognosis, typically managed with a multidisciplinary approach including surgery, chemotherapy, and radiotherapy.
Why the study?
Cardiac angiosarcoma is rare, difficult to diagnose due to non-specific symptoms, lacks established treatment guidelines, and carries a poor prognosis.
This review highlights the diagnostic challenges and poor prognosis of cardiac angiosarcoma, emphasizing the need for multidisciplinary treatment and future targeted therapies.
No takes yet. Share an insight, caveat, or question.
Supports multidisciplinary management for this rare tumor; leaves open targeted therapy development.
OŁOWNIA et al. (2023) conducted a review in Primary cardiac angiosarcoma. Surgical resection, chemotherapy, and radiotherapy was evaluated. Primary cardiac angiosarcoma is a rare and aggressive malignancy with a poor prognosis, typically managed with a multidisciplinary approach including surgery, chemotherapy, and radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: